R. G. Tieleman

“Early” Class III Drugs for the Treatment of Atrial Fibrillation

Yuri Blaauw, Heinz Gögelein, R. G. Tieleman et al. · Circulation · 2004 · 171 citations · Full text

Medicine, Cardiology, Pharmacology +17

Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias.

R. G. Tieleman, Harry J. Crijns, Ans C.P. Wiesfeld et al. · Heart · 1995 · 72 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study

M T H M Henkens, AG Raafs, Job A.J. Verdonschot et al. · BMC Geriatrics · 2022 · 70 citations · Full text

Medicine, Geriatric Medicine, Clinical Epidemiology +16

Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries

Marijke Linschoten, Alicia Uijl, Astrid Schut et al. · European Heart Journal · 2021 · 55 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Long-term outcome of electrical cardioversion in patients with chronic atrial flutter.

Harry J. Crijns, I. C. Van Gelder, R. G. Tieleman et al. · Heart · 1997 · 47 citations · Full text

Medicine, Cardiology, Pharmacology +13